Article Details

MacroGenics' HER2 breast cancer drug Margenza approved in US

Retrieved on: 2020-12-18 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

MacroGenics' HER2 breast cancer drug Margenza approved in US. View article details on hiswai:

Excerpt

... Clinical Oncology (ASCO) in 2019, Margenza is a tweaked version of <b>Roche's</b> Herceptin (trastuzumab), which dominated the HER2-mutated breast ...

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up